# Novartis Pharma AG – FDA Inspection, Jul 6, 2017

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharma-ag/25132932-baad-4786-893f-6aa8f8fa697b
Source feed: FDA_Inspections

> FDA inspection 1021086 of Novartis Pharma AG, July 06, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021086
- Company Name: Novartis Pharma AG
- Inspection Date: 2017-07-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1180833 - 2022-08-30
- [FDA Inspection 1109986 - 2019-08-29](https://www.keypedia.com/records/fda_inspections/novartis-pharma-ag/0857ce8e-6530-4997-b440-9f2dae82399a)
- FDA Inspection 1099919 - 2019-07-12
- FDA Inspection 1053787 - 2018-04-20
- FDA Inspection 916149 - 2015-01-14

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/novartis-pharma-ag/194ac641-5956-4430-9641-411cb975a51f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c